Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01449981 · ClinicalTrials.gov registry record · NA
Development and Testing of Adolescent Twelve-Step Facilitation
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
NCT01449981: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01449981 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 59 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01449981, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
Study Summary
This study is the first to develop and test in a randomized experimental design the efficacy of an integrated 12-step facilitation intervention tailored for young people. In the first phase of the study, the investigators are developing and revising a preliminary manual for the two sessions individually-delivered Motivational Enhancement Therapy (MET) component and subsequent 8 session group-delivered Cognitive-Behavioral Therapy (CBT) component which will integrate Twelve-step Facilitation (TSF). Forty adolescents each will complete the preliminary integrated TSF protocol. In the second phase of the study, the investigators will compare integrated TSF (iTSF) to standard treatment (MET/CBT) in a randomized experimental design for adolescent substance use disorder with 60 adolescents. As a result, the investigators will examine potential mechanisms that may underlie the efficacy of iTSF in improving alcohol and other drug use outcomes. The investigators will test group differences on potential mechanisms of change (e.g., Alcoholics Anonymous/Narcotics Anonymous attendance and involvement) and whether these variables are associated with substance use outcomes.
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy
- BEHAVIORAL Integrated Twelve-Step Facilitation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2011-10 |
| Est. Completion | 2016-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01449981
The ClinicalTrials.gov registry entry for NCT01449981 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cognitive Behavioral Therapy is the first listed.
NCT01449981 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01449981 about?
NCT01449981 is a clinical study titled "Development and Testing of Adolescent Twelve-Step Facilitation". This study is the first to develop and test in a randomized experimental design the efficacy of an integrated 12-step facilitation intervention tailored for young people. In the first phase of the study, the investigators are developing and revising a preliminary manual for the two sessions individu...
What is the current status of trial NCT01449981?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2011-10. Estimated completion is 2016-01.
What interventions are being tested in trial NCT01449981?
The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL), Integrated Twelve-Step Facilitation (BEHAVIORAL).
Who is sponsoring clinical trial NCT01449981?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.